Market Overview

Benzinga's Top Upgrades

Benzinga's Top Upgrades

Analysts at Goldman Sachs upgraded First Solar, Inc. (NASDAQ: FSLR) from Sell to Neutral. The price target for First Solar is set to $44. First Solar's shares closed at $40.86 yesterday.

Analysts at Sterne Agee upgraded Invesco Ltd. (NYSE: IVZ) from Neutral to Buy. The price target for Invesco has been raised from $45 to $47. Invesco's shares closed at $37.21 yesterday.

JP Morgan upgraded Janus Capital Group, Inc. (NYSE: JNS) from Underweight to Overweight. The price target for Janus Capital has been raised from $16 to $20. Janus Capital's shares closed at $15.56 yesterday.

Analysts at Janney Capital upgraded Progressive Corp. (NYSE: PGR) from Neutral to Buy. Progressive's shares closed at $26.41 yesterday.

Latest Ratings for FSLR

Jan 2019BarclaysInitiates Coverage OnOverweight
Jan 2019Goldman SachsUpgradesNeutralBuy
Dec 2018Morgan StanleyMaintainsEqual-WeightEqual-Weight

View More Analyst Ratings for FSLR
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings


Related Articles (FSLR + IVZ)

View Comments and Join the Discussion!

Latest Ratings

DRIBank of AmericaReiterates130.0
PVACNorthland SecuritiesUpgrades0.0
NKEWells FargoMaintains80.0
DRIWells FargoMaintains120.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Trader Essentials
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

Why Brian Sozzi Isn't Surprised By The Surge In Sonic's Shares

Wells Fargo Initiates Immunomedics At Outperform